Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)

SHA:603229 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	794.8	792.76	795.29	816.77	764.55	569.7
Revenue Growth	-0.78%	-0.32%	-2.63%	6.83%	34.20%	39.21%
Gross Profit Gross Profit Growth	410.11	404.61	421.9	444.36	391.96	308.41
Operating Income Operating Income Growth	118.05	117.21	184.48	244.54	205.2	152.2
Net Income Net Income Growth	108.03	130.57	206.79	253.9	235.38	145.93
Earnings Per Share EPS Growth	0.13	0.16	0.25	0.31	0.29	0.18
EPS Growth	-47.23%	-36.00%	-19.36%	5.84%	59.45%	57.55%

Revenue by Segment

Chart

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
Raw Materials and Intermediates Raw Materials and Intermediates Growth	754.04
Fees for Technical Services Fees for Technical Services Growth	36.83
Pharmaceutical Preparation Pharmaceutical Preparation Growth	1.89
Total Total Growth	792.76

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1,154	1,227	1,099	1,124	612.87	674.55
Total Debt Total Debt Growth	486.22	456.65	272.43	303.17	242.02	109.93
Net Cash (Debt) Net Cash Growth	667.38	769.86	826.1	821.06	370.85	564.62
Net Cash Growth	-18.39%	-6.81%	0.61%	121.40%	-34.32%	-19.12%
Net Cash Per Share Net Cash Per Share Growth	0.83	0.94	1.00	1.00	0.46	0.71

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	120.43	156.51	177.93	221.85	120.57	173.9
Capital Expenditures CapEx Growth	-94.86	-104.45	-111.3	-163.47	-271.91	-310.85
Free Cash Flow Free Cash Flow Growth	25.56	52.06	66.62	58.38	-151.35	-136.95
Free Cash Flow Growth	-9.19%	-21.85%	14.12%	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	51.60%	51.04%	53.05%	54.40%	51.27%	54.14%
Operating Margin	14.85%	14.79%	23.20%	29.94%	26.84%	26.72%
Pretax Margin	13.65%	17.40%	30.20%	35.60%	33.47%	27.98%
Profit Margin	13.59%	16.47%	26.00%	31.09%	30.79%	25.61%
FCF Margin	3.22%	6.57%	8.38%	7.15%	-19.80%	-24.04%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.064	0.064	0.100	0.092	0.057	0.037
Dividend Per Share Growth	-36.00%	-36.00%	8.58%	61.30%	53.91%	62.72%
Dividend Yield	0.86%	0.65%	1.02%	1.01%	0.49%	0.29%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	55.26	62.93	40.11	30.86	40.64	71.62
Forward PE	-	34.21	25.95	22.58	34.87	54.34
P/FCF Ratio	239.48	157.82	124.50	134.20	-	-
PS Ratio	7.70	10.37	10.43	9.59	12.51	18.35

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error